REFERENCES
- Krishnakumar S, Mallikarjuna K, Desai N, Muthialu A, Venkatesan N, Sundaram A, Khetan V, Shanmugam MP. Multidrug resistance proteins: P-glycoprotein and lung resistance protein expression in retinoblastoma. BJO 2004;88:1521–1526.
- Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 1985;70:291–301.
- Tan B, Piwnica-Worms D, Ratner L. Multidrug resistance transporters and modulation. Curr Opin Oncol 2000;12:450–458.
- Lee E, Lim S-J. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines. Arch Pharm Res 2006;29:1018–1023.
- Izquierdo MA, Scheffer GL, Flens MJ, Schroeijers AB, Vander Valk P, Scheper RJ. Major vault protein LRP-related multidrug resistance. Euro J Can 1996;32A:979–984.
- Kitazono M, Sumizawa T, Takebayashi Y, Chen Z-S, Furukawa T, Nagayama S, Tani A, Takao S, Aikou T, Akiyama S-I. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 1999;91:1647–1653.
- Mossink MH, van Zon A, Scheper RJ, Sonnevel P, Wiemer EAC. Vaults: A ribonuclear protein particle involved in multidrug resistance? Oncogene 2003;22:7458–7467.
- Yanagisawa T. Systemic chemotherapy as a new conservative treatment for intraocular retinoblastoma. Int J Clin Onco 2004;9:13–24.
- Eckstein LA, Van Quill KR, Bui SK, Uusitalo MS, O’Brien JM. Cyclosporin A inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells. IOVS 2005;46:782–790.
- Chearwae W, Anuchapreeda S, Nandigama K, Ambudkar SV, Limtrakul P. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from turmeric powder. Biochem Pharm 2004;68:2043–2052.
- Anuchapreeda S, Leechanachai P, Smith MM, Ambudhkar SV, Limtrakul P. Modulation of P-glycoprotein expression and function by curcumin in multidrug resistance human KB cells. Biochem Pharm 2002; 64:573–582.
- Limtrakul P, Anuchapreeda S, Buddhasukh D. Modulation of human multidrug resistance MDR1 gene by natural curcuminoids. BMC Cancer 2004;13:1–6.
- Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Can Res 2007;67:1988–1996.
- Waiwut P, Anuchapreeda S, Limtrakul P-N. Curcumin inhibits P-glycoprotein level in the caricinoma of cervix cells (KB-carcinoma cell lines) induced by vinblastine. Chiang Mai Med Bull 2002;41:139–145.
- Tang X-Q, BI H, Feng J-Q, Cao J-G. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharma Sinica 2005;26:1009–1016.
- Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–275.
- Bharat BA, Kumar A, Aggarwal MS, Shishodia S. Phytopharmaceuticals in cancer chemoprevention. Curcumin derived from Turmeric (Curcumo longa): A spice for all seasons. Phytopharmaceuticals in Cancer Chemoprevention 2005; 349–387.
- Chearwae W, Wu C-P, Chu Hr, Lee TR, Ambudkar SV, Limtrakul P. Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemo Pharma 2006;57:376–388.
- Beevers CS, Li F, Liu L, Huang S. Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells. Int J Can 2006;119:757–764.
- Syng-ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2. Molec Cancer Therapeut 2004;3:1101–1108.
- Chearwae W, Shukla S, Limtrakul P, Ambudhkar SV. Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin. Mol Cancer Ther 2006;5:1995–2006.
- Steiner E, Holzmann K, Pircker C, Elbling L, Micksche M, Sutterluty H, Berger W. The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals. J Cell Sci 2006;119:459–469.